165 related articles for article (PubMed ID: 30032527)
1. [Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2018 version)].
Pancreatic Cancer Committee of Chinese Anti-Cancer Association
Zhonghua Wai Ke Za Zhi; 2018 Jul; 56(7):481-494. PubMed ID: 30032527
[TBL] [Abstract][Full Text] [Related]
2. [Comprehensive guidelines for the diagnosis and treatment of pancreatic cancer (2020 version)].
Pancreatic Cancer Committee of Chinese Anticancer Association
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):81-100. PubMed ID: 33378799
[TBL] [Abstract][Full Text] [Related]
3. Advances in the surgical management of pancreatic cancer.
Spanknebel K; Conlon KC
Cancer J; 2001; 7(4):312-23. PubMed ID: 11561607
[TBL] [Abstract][Full Text] [Related]
4. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
5. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
Schwarz L; Katz MH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
[TBL] [Abstract][Full Text] [Related]
7. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer.
Pedrazzoli S; Beger HG; Obertop H; Andrén-Sandberg A; Fernández-Cruz L; Henne-Bruns D; Lüttges J; Neoptolemos JP
Dig Surg; 1999; 16(4):337-45. PubMed ID: 10449979
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
[TBL] [Abstract][Full Text] [Related]
9. Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy.
di Sebastiano P; Grottola T; di Mola FF
Updates Surg; 2016 Sep; 68(3):235-239. PubMed ID: 27629483
[TBL] [Abstract][Full Text] [Related]
10. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis.
Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T;
Jpn J Clin Oncol; 2014 Oct; 44(10):883-8. PubMed ID: 25205672
[TBL] [Abstract][Full Text] [Related]
11. Strategies to improve local control of resected pancreas adenocarcinoma.
Sugarbaker PH
Surg Oncol; 2017 Mar; 26(1):63-70. PubMed ID: 28317586
[TBL] [Abstract][Full Text] [Related]
12. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
Wang G; Zhou D
Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
[TBL] [Abstract][Full Text] [Related]
13. Can Neoadjuvant Therapy in Pancreatic Cancer Increase the Pool of Patients Eligible for Pancreaticoduodenectomy?
Hackert T; Ulrich A; Büchler MW
Adv Surg; 2017 Sep; 51(1):1-10. PubMed ID: 28797331
[No Abstract] [Full Text] [Related]
14. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
[TBL] [Abstract][Full Text] [Related]
15. [The guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition)].
;
Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):657-667. PubMed ID: 32878410
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic pancreaticoduodenectomy for tumors of the head of pancreas; 10 cases for a single center experience.
Caruso F; Alessandri G; Cesana G; Castello G; Uccelli M; Ciccarese F; Giorgi R; Villa R; Scotto B; Olmi S
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3745-3753. PubMed ID: 28975996
[TBL] [Abstract][Full Text] [Related]
17. Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.
Kang CM; Hwang HK; Choi SH; Lee WJ
Surg Oncol; 2013 Jun; 22(2):123-31. PubMed ID: 23518243
[TBL] [Abstract][Full Text] [Related]
18. Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.
Miyazaki M; Yoshitomi H; Takano S; Shimizu H; Kato A; Yoshidome H; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Ohtuka M
Langenbecks Arch Surg; 2017 May; 402(3):447-456. PubMed ID: 28361216
[TBL] [Abstract][Full Text] [Related]
19. Role of surgery in the treatment of bilio-pancreatic cancer: the European experience.
Pedrazzoli S; Pasquali C; Sperti C
Semin Oncol; 2002 Dec; 29(6 Suppl 20):23-30. PubMed ID: 12577230
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant strategy as initial treatment in resectable pancreatic cancer: concrete evidence of benefit.
DE Felice F; Musio D; Raffetto N; Tombolini V
Anticancer Res; 2014 Sep; 34(9):4673-6. PubMed ID: 25202043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
